Mathematical modeling of pulmonary tuberculosis therapy: insights from a prototype model with rifampin

DOI10.1016/j.jtbi.2011.05.013zbMath1397.92329OpenAlexW1989833079WikidataQ43447784 ScholiaQ43447784MaRDI QIDQ1783605

Laurent Bourguignon, Pascal Maire, Roger W. Jelliffe, John E. jun. Conte, Sylvain Goutelle

Publication date: 21 September 2018

Published in: Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.jtbi.2011.05.013

zbMATH Keywords

simulationsmathematical modeltuberculosispharmacokineticspharmacodynamics

Mathematics Subject Classification ID

Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45) Medical applications (general) (92C50)

Related Items (3)

Mathematical modeling and systems pharmacology of tuberculosis: isoniazid as a case study ⋮ A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment ⋮ Nonlinear growth and mathematical modelling of COVID-19 in some African countries with the Atangana-Baleanu fractional derivative

Cites Work

• Identifying control mechanisms of granuloma formation during \textit{M. tuberculosis} infection using an agent-based model
• The human immune response to \textit{Mycobacterium tuberculosis} in lung and lymph node
• MATHEMATICAL MODELING OF CHEMOTHERAPY OF HUMAN TB INFECTION

This page was built for publication: Mathematical modeling of pulmonary tuberculosis therapy: insights from a prototype model with rifampin